ID15917A - METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS - Google Patents

METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS

Info

Publication number
ID15917A
ID15917A IDP970182A ID970182A ID15917A ID 15917 A ID15917 A ID 15917A ID P970182 A IDP970182 A ID P970182A ID 970182 A ID970182 A ID 970182A ID 15917 A ID15917 A ID 15917A
Authority
ID
Indonesia
Prior art keywords
obligation
methods
large column
tumors
column tumors
Prior art date
Application number
IDP970182A
Other languages
Indonesian (id)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID15917A publication Critical patent/ID15917A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
IDP970182A 1996-01-29 1997-01-22 METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS ID15917A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
ID15917A true ID15917A (en) 1997-08-21

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970182A ID15917A (en) 1996-01-29 1997-01-22 METHODS FOR OBLIGATION OF LARGE COLUMN TUMORS

Country Status (19)

Country Link
EP (1) EP0921799A4 (en)
JP (1) JP2000503994A (en)
KR (1) KR19990082054A (en)
CN (1) CN1209745A (en)
AR (1) AR010978A1 (en)
AU (1) AU707892B2 (en)
BR (1) BR9700778A (en)
CO (1) CO4761062A1 (en)
CZ (1) CZ235498A3 (en)
EA (1) EA001104B1 (en)
ID (1) ID15917A (en)
IL (1) IL125521A (en)
MX (1) MX9806036A (en)
NO (1) NO983451L (en)
NZ (1) NZ331105A (en)
PL (1) PL328147A1 (en)
TW (1) TW446560B (en)
WO (1) WO1997026877A1 (en)
YU (1) YU2397A (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CA2118096A1 (en) * 1993-10-15 1995-04-16 Srinivasan Chandrasekhar Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
JP2000503994A (en) 2000-04-04
BR9700778A (en) 1998-10-06
AU707892B2 (en) 1999-07-22
EA199800677A1 (en) 1999-02-25
EP0921799A4 (en) 2002-03-13
EA001104B1 (en) 2000-10-30
CO4761062A1 (en) 1999-04-27
NO983451D0 (en) 1998-07-27
IL125521A0 (en) 1999-03-12
CZ235498A3 (en) 1999-02-17
YU2397A (en) 1999-11-22
TW446560B (en) 2001-07-21
NO983451L (en) 1998-07-27
IL125521A (en) 2001-11-25
PL328147A1 (en) 1999-01-18
KR19990082054A (en) 1999-11-15
AR010978A1 (en) 2000-08-02
WO1997026877A1 (en) 1997-07-31
EP0921799A1 (en) 1999-06-16
AU2123997A (en) 1997-08-20
CN1209745A (en) 1999-03-03
MX9806036A (en) 1998-11-29
NZ331105A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
DE69735643D1 (en) IL12 for gene therapy of tumors
NO971015L (en) Compounds and Methods for the Treatment of Cancer
FI980038L (en) Tumor necrosis factor alpha inhibitors
NO994069D0 (en) Compounds for the Prostate Cancer Immunotherapy and Method of Use
ID19886A (en) COMBINED THERAPY FOR OSTEOPOROSIS
DE69713295D1 (en) AZABICYCLISHE CARBANIUMSAUREESTER FOR THERAPEUTIC USE
NO991955L (en) Process for the treatment of hydrocarbons
NO984431D0 (en) Procedure for treating pain
DK0972201T3 (en) Compounds for immune diagnosis of prostate cancer and methods for its use
ATE239509T1 (en) CONJUGATES FOR THE TREATMENT OF PROSTATE CANCER
DE69724201D1 (en) DATA DECODER
IS5035A (en) Methods for the prevention of breast cancer
NO986177D0 (en) Method of Preparation of Therapeutic DNA
NO983090D0 (en) Therapeutic compounds
FI960658A7 (en) New bis-naphthalimides for cancer treatment
NO984446D0 (en) Procedure for treating pain
FI941936A0 (en) column shoe
DE59702725D1 (en) SIGNAL COLUMN
NO981435L (en) Write
ID20291A (en) SUBSTITUTED OXYCUTIRATIC ACIDS AS METHODS OF METALOPROTEASA MATRIERS
DE69722350D1 (en) Rotating bed for tanning
FI970717L (en) Methods for inhibiting uterine cancer
DE59710651D1 (en) sound therapy
FI95164C (en) Column Shoe
KR970053540U (en) Acupuncture for acupuncture